Vitamin D, in the form of CALIFEDIOL still not as the video of yesterday discus

 More than 99% (n=3600) of treated patients received subcutaneous heparin or enoxaparin.  Enoxaparin is an anticoagulant, also known as a “blood thinner.” It is a type of heparin BMJ

Conclusions Early initiation of prophylactic anticoagulation compared with no anticoagulation among patients admitted to hospital with covid-19 was associated with a decreased risk of 30 day mortality and no increased risk of serious bleeding events. These findings provide strong real world evidence to support guidelines recommending the use of prophylactic anticoagulation as initial treatment for patients with covid-19 on hospital admission. BMJ